Novocure (NVCR) Tops Q3 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $167 million versus the consensus estimate of $158.54 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Trex (TREX) Reiterated at Hold by Benchmark as Partnership Agreement Announced
• The Chefs' Warehouse, Inc (CHEF) PT Raised to $106 at Benchmark on Growth Assumption
• Stephens Upgrades WESCO International (WCC) to Overweight